136 related articles for article (PubMed ID: 31785863)
1. Using evidence to direct quality improvement efforts: Defining the highest impact complications after complex cytoreductive surgery for ovarian cancer.
Narasimhulu DM; Bews KA; Hanson KT; Chang YH; Dowdy SC; Cliby WA
Gynecol Oncol; 2020 Feb; 156(2):278-283. PubMed ID: 31785863
[TBL] [Abstract][Full Text] [Related]
2. Associations of Specific Postoperative Complications With Outcomes After Elective Colon Resection: A Procedure-Targeted Approach Toward Surgical Quality Improvement.
Scarborough JE; Schumacher J; Kent KC; Heise CP; Greenberg CC
JAMA Surg; 2017 Feb; 152(2):e164681. PubMed ID: 27926773
[TBL] [Abstract][Full Text] [Related]
3. Which postoperative complications matter most after bariatric surgery? Prioritizing quality improvement efforts to improve national outcomes.
Daigle CR; Brethauer SA; Tu C; Petrick AT; Morton JM; Schauer PR; Aminian A
Surg Obes Relat Dis; 2018 May; 14(5):652-657. PubMed ID: 29503096
[TBL] [Abstract][Full Text] [Related]
4. Outcomes Associated With a Five-Point Surgical Site Infection Prevention Bundle in Women Undergoing Surgery for Ovarian Cancer.
Lippitt MH; Fairbairn MG; Matsuno R; Stone RL; Tanner EJ; Wick EC; Angarita AC; Roche KL; Levinson KL; Bergstrom JE; Sinno AK; Curless MS; Wethington S; Temkin SM; Efron J; Hobson D; Fader AN
Obstet Gynecol; 2017 Oct; 130(4):756-764. PubMed ID: 28885412
[TBL] [Abstract][Full Text] [Related]
5. Bowel resection or repair at the time of cytoreductive surgery for ovarian malignancy is associated with increased complication rate: An ACS-NSQIP study.
Bernard L; Boucher J; Helpman L
Gynecol Oncol; 2020 Sep; 158(3):597-602. PubMed ID: 32641239
[TBL] [Abstract][Full Text] [Related]
6. Hospital readmission after ovarian cancer surgery: Are we measuring surgical quality?
Barber EL; Doll KM; Gehrig PA
Gynecol Oncol; 2017 Aug; 146(2):368-372. PubMed ID: 28522108
[TBL] [Abstract][Full Text] [Related]
7. Quality Improvement Initiatives in Colorectal Surgery: Value of Physician Feedback.
Waters JA; Francone T; Marcello PW; Roberts PL; Schoetz DJ; Read TE; Stafford C; Ricciardi R
Dis Colon Rectum; 2017 Feb; 60(2):213-218. PubMed ID: 28059918
[TBL] [Abstract][Full Text] [Related]
8. Unanticipated 30-day readmission following rectosigmoid resection at the time of cytoreductive surgery in patients with advanced stage ovarian cancer.
Sanders BE; Saharti S; Laus K; Bristow RE; Eskander RN
J Obstet Gynaecol; 2021 Aug; 41(6):956-961. PubMed ID: 33228421
[TBL] [Abstract][Full Text] [Related]
9. Association of Clinical Risk Factors and Postoperative Complications With Unplanned Hospital Readmission After Head and Neck Cancer Surgery.
Bur AM; Brant JA; Mulvey CL; Nicolli EA; Brody RM; Fischer JP; Cannady SB; Newman JG
JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1184-1190. PubMed ID: 27737442
[TBL] [Abstract][Full Text] [Related]
10. Thirty-day readmission and reoperation after surgery for spinal tumors: a National Surgical Quality Improvement Program analysis.
Karhade AV; Vasudeva VS; Dasenbrock HH; Lu Y; Gormley WB; Groff MW; Chi JH; Smith TR
Neurosurg Focus; 2016 Aug; 41(2):E5. PubMed ID: 27476847
[TBL] [Abstract][Full Text] [Related]
11. Targeting the most important complications in vascular surgery.
Bennett KM; Kent KC; Schumacher J; Greenberg CC; Scarborough JE
J Vasc Surg; 2017 Mar; 65(3):793-803. PubMed ID: 28236921
[TBL] [Abstract][Full Text] [Related]
12. Management of morbidity associated with pancreatic resection during cytoreductive surgery for epithelial ovarian cancer: A systematic review.
Di Donato V; Bardhi E; Tramontano L; Capomacchia FM; Palaia I; Perniola G; Plotti F; Angioli R; Giancotti A; Muzii L; Panici PB
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):694-702. PubMed ID: 31806515
[TBL] [Abstract][Full Text] [Related]
13. Morbidity and Mortality Rates Following Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Compared With Other High-Risk Surgical Oncology Procedures.
Foster JM; Sleightholm R; Patel A; Shostrom V; Hall B; Neilsen B; Bartlett D; Smith L
JAMA Netw Open; 2019 Jan; 2(1):e186847. PubMed ID: 30646202
[TBL] [Abstract][Full Text] [Related]
14. Hospital-acquired conditions after bariatric surgery: we can predict, but can we prevent?
Lidor AO; Moran-Atkin E; Stem M; Magnuson TH; Steele KE; Feinberg R; Schweitzer MA
Surg Endosc; 2014 Dec; 28(12):3285-92. PubMed ID: 24935201
[TBL] [Abstract][Full Text] [Related]
15. Impact of omentoplasty on anastomotic leak and septic complications after low pelvic anastomosis: a study from the NSQIP database.
Ozben V; Ozuner G; Isik O; Gorgun E; Stocchi L; Liu X
Int J Colorectal Dis; 2018 Dec; 33(12):1733-1739. PubMed ID: 30171353
[TBL] [Abstract][Full Text] [Related]
16. Predictive and Prognostic Implication of Bowel Resections During Primary Cytoreductive Surgery in Advanced Epithelial Ovarian Cancer.
Bartl T; Schwameis R; Stift A; Bachleitner-Hofmann T; Reinthaller A; Grimm C; Polterauer S
Int J Gynecol Cancer; 2018 Nov; 28(9):1664-1671. PubMed ID: 30371563
[TBL] [Abstract][Full Text] [Related]
17. Assessment of poor functional status and post-acute care needs following primary ovarian cancer debulking surgery.
Roy AG; Brensinger CM; Latif N; Giuntoli R; Kim S; Morgan M; Ko EM
Int J Gynecol Cancer; 2020 Feb; 30(2):227-232. PubMed ID: 31911537
[TBL] [Abstract][Full Text] [Related]
18. Benefit of negative pressure drain within surgical wound after cytoreductive surgery for ovarian cancer.
Kim SI; Lim MC; Bae HS; Shin SR; Seo SS; Kang S; Park SY
Int J Gynecol Cancer; 2015 Jan; 25(1):145-51. PubMed ID: 25386858
[TBL] [Abstract][Full Text] [Related]
19. Thirty-day unplanned hospital readmission in ovarian cancer patients undergoing primary or interval cytoreductive surgery: systematic literature review.
Clark RM; Rice LW; Del Carmen MG
Gynecol Oncol; 2018 Aug; 150(2):370-377. PubMed ID: 29929923
[TBL] [Abstract][Full Text] [Related]
20. Unplanned postoperative intensive care unit admission for ovarian cancer cytoreduction is associated with significant decrease in overall survival.
Ross MS; Burriss ME; Winger DG; Edwards RP; Courtney-Brooks M; Boisen MM
Gynecol Oncol; 2018 Aug; 150(2):306-310. PubMed ID: 29929924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
